Personalized Medicine – Products

Company introduces their new site, featuring free poster and protocol downloads as well as updated information on the CellInsight™ platform and REACT-lipid™ service.

Development of tissue-based biomarker strategy for the treatment of solid cancers.

The portal provides information and decision making tools that will help patients understand how genetic testing can be used to inform treatment decisions and enable better communication between patients and providers.

Company launches a web-based portal for Canadians and joined DNA Direct by Medco's GMN.

Affymetrix, Inc. announced that its GeneChip® System 3000Dx v.2 (GCS 3000Dx v.2) has been approved by China's State Food and Drug Administration (SFDA) for in vitro diagnostic use.

These presentations represent the first re-sequencing data ever generated using a single-molecule, solid-state DNA sequencing platform.

High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients.

The Center for Human Genetics and Laboratory Medicine and IMGM Laboratories reported using the benchtop system to sequence clinically relevant exons and identify genomic variations in solid tumors treated with an antibody-based medicine.

New histology line-up addresses inconsistent preparation of samples in biomedical research and diagnostics.

New Comprehensive MDx LIMS Designed Specifically for Molecular Diagnostics Laboratories